Intergenerational monitoring in clinical trials of germline gene editing.

Clinical trials Gene Therapy/Transfer Reproductive Medicine Research Ethics

Journal

Journal of medical ethics
ISSN: 1473-4257
Titre abrégé: J Med Ethics
Pays: England
ID NLM: 7513619

Informations de publication

Date de publication:
03 2020
Historique:
received: 12 06 2019
revised: 14 08 2019
accepted: 21 08 2019
pubmed: 2 9 2019
medline: 18 9 2021
entrez: 2 9 2019
Statut: ppublish

Résumé

Design of clinical trials for germline gene editing stretches current accepted standards for human subjects research. Among the challenges involved is a set of issues concerning

Identifiants

pubmed: 31473657
pii: medethics-2019-105620
doi: 10.1136/medethics-2019-105620
pmc: PMC7036322
mid: NIHMS1050009
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

183-187

Subventions

Organisme : NHGRI NIH HHS
ID : R03 HG010417
Pays : United States

Informations de copyright

© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: BC reports grants from the National Human Genome Research Institute during the conduct of the study. Shoukhrat Mitalipov, director of the Oregon Health and Science University Center for Embryonic, Cell, and Gene Therapy, and principal investigator and coauthor of two studies on germline gene therapy cited in this paper, is on the advisory committee for a grant that funded work on this paper.

Références

Am J Bioeth. 2015;15(12):35-7
pubmed: 26632359
Br Med Bull. 2018 Sep 1;127(1):23-31
pubmed: 30202929
Reprod Biomed Online. 2016 Dec;33(6):737-744
pubmed: 27789184
Nat Med. 2019 Jun;25(6):890-897
pubmed: 31160821
Am J Hum Genet. 2004 Apr;74(4):599-609
pubmed: 14991528
Hum Fertil (Camb). 2018 Sep;21(3):156-162
pubmed: 28438071
Nature. 2019 Mar;567(7747):165-168
pubmed: 30867611
N Engl J Med. 2017 Nov 16;377(20):1911-1913
pubmed: 29141166
Am J Bioeth. 2015;15(12):25-9
pubmed: 26632357
Camb Q Healthc Ethics. 2019 Oct;28(4):695-707
pubmed: 31526421
Nature. 2018 Nov;563(7733):607-608
pubmed: 30482929
Nature. 2017 Aug 24;548(7668):413-419
pubmed: 28783728
Nat Biotechnol. 2018 Sep;36(8):765-771
pubmed: 30010673
Trends Mol Med. 2015 Feb;21(2):68-76
pubmed: 25573721
IRB. 2004 Sep-Oct;26(5):1-8
pubmed: 15658011
Am J Hum Genet. 2017 Aug 3;101(2):167-176
pubmed: 28777929
N Engl J Med. 2018 Apr 05;378(14):1323-1334
pubmed: 29617578
J Zhejiang Univ Sci B. 2013 May;14(5):359-71
pubmed: 23645173
Reprod Biomed Online. 2013 Nov;27(5):477-85
pubmed: 23933034
Nature. 2018 Oct;562(7726):203-209
pubmed: 30305743
Mol Ther. 2015 Aug;23(8):1282
pubmed: 26227250
Am J Epidemiol. 2007 Jun 1;165(11):1328-35
pubmed: 17372189
Pediatr Neurol. 2019 Nov;100:3-11
pubmed: 31371124

Auteurs

Bryan Cwik (B)

Philosophy and University Studies, Portland State University, Portland, Oregon, USA bcwik@pdx.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH